Figure 2From: Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsImpact of timed daily bromocriptine or vehicle administration on body weight (Panel A), retroperitoneal fat pad (Panel B), food consumptions (Panel C) and liver triglycerides (Panel D). Values are means ± SEM of 8 animals in each group. *Difference is statistically significant; P values are noted under each panel.Back to article page